Behaviour of Staphylococcus aureus during sufu production at laboratory scale

被引:5
|
作者
Han, BZ
Sesenna, B
Beumer, RR
Nout, MJR
机构
[1] Univ Wageningen & Res Ctr, Food Microbiol Lab, Dept Agrotechnol & Food Sci, NL-6700 EV Wageningen, Netherlands
[2] Chinese Acad Sci, Coll Food Sci & Nutrit Engn, Beijing 100083, Peoples R China
关键词
safety; tofu; pehtze; brine; Aactinonnicor elegans; enterotoxin; salt tolerance;
D O I
10.1016/j.foodcont.2004.03.001
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Sufu is a Chinese soybean cheese, obtained by fungal fermentation of soybean curd (tofu) with Actinomucor elegans to yield pehtze, followed by enzymatic maturation in brine solution containing 12-16%, (w/w) of NaCl for 2-6 months. After equilibration, the final product, sufu, usually contains half of the NaCl concentration of the brine used. We studied the behaviour (survival, growth, formation of enterotoxins) of several strains of Staphylococcus aureus in a laboratory- sea le simulation of the production of sufu. Of 15 S. aureus strains tested, strains No. 1, 3, 4, 5, 8, 9, and 10 showed good growth in sterile Brain Heart Infusion broth with high (6-12%, w/w) NaCl concentration, demonstrating their halotolerance. S. aureus growth was not negatively influenced by A. elegans, and no interaction between the mould and the bacterial strains was observed during pehtze preparation. S. aureus strains No. 3 and 5 were selected for maturation experiments because they grew up to 8.9-9.5 log cfu/g and they produced their typical enterotoxin in all substrates tested. With the objective of creating a worst-case scenario, halotolerant enterotoxin producing S. aureus strains were inoculated at several stages of the sufu model system. Levels of 6% and 12% of NaCl in the brine solution were still too low to inhibit their growth and enterotoxin production. Even 18% of NaCl in the brine solution could not inhibit their growth, but enterotoxin production was prevented. Brine solution with 24% of NaCl inhibited growth as well as enterotoxin production. In conclusion, a salt concentration of 9%, in the final product will be a minimum safeguard against S. aureus enterotoxin formation. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:243 / 247
页数:5
相关论文
共 50 条
  • [41] Behaviour of Staphylococcus aureus Strains FRI 137 and FRI 361 During the Manufacture and Ripening of Manchego Cheese
    Otero, A.
    Garcia, M. C.
    Garcia, M. L.
    Santos, J. A.
    Moreno, B.
    INTERNATIONAL DAIRY JOURNAL, 1993, 3 (01) : 85 - 96
  • [42] The development of dehyrogenase in staphylococcus aureus during cultivation
    Bach, D
    COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES, 1935, 120 : 673 - 674
  • [43] The mutational landscape of Staphylococcus aureus during colonisation
    Coll, Francesc
    Blane, Beth
    Bellis, Katherine L.
    Matuszewska, Marta
    Wonfor, Toska
    Jamrozy, Dorota
    Toleman, Michelle S.
    Geoghegan, Joan A.
    Parkhill, Julian
    Massey, Ruth C.
    Peacock, Sharon J.
    Harrison, Ewan M.
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [44] Metastatic infection during Staphylococcus aureus bacteremia
    Horino, Tetsuya
    Hori, Seiji
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2020, 26 (02) : 162 - 169
  • [45] Simvastatin is protective during Staphylococcus aureus pneumonia
    McDowell, S. A.
    Ma, Y.
    Akinbi, H. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [46] STAPHYLOCOCCUS-AUREUS BACTEREMIA DURING THERAPY
    ENG, RHK
    BISHBURG, E
    SMITH, SM
    SCADUTTO, P
    JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (06): : 1331 - 1335
  • [47] Epidemiology of Staphylococcus aureus during space flight
    Pierson, DL
    Chidambaram, M
    Heath, JD
    Mallary, L
    Mishra, SK
    Sharma, B
    Weinstock, GM
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1996, 16 (3-4): : 273 - 281
  • [48] Evolution of Staphylococcus aureus and MRSA during outbreaks
    Lindsay, Jodi A.
    INFECTION GENETICS AND EVOLUTION, 2014, 21 : 548 - 553
  • [49] Simvastatin is Protective During Staphylococcus aureus Pneumonia
    McDowell, Susan A.
    Ma, Yan
    Kusano, Ryosuke
    Akinbi, Henry T.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (09) : 1455 - 1462
  • [50] Immunogenicity of Toxins during Staphylococcus aureus Infection
    Verkaik, Nelianne J.
    Dauwalder, Olivier
    Antri, Kenza
    Boubekri, Ilhem
    de Vogel, Corne P.
    Badiou, Cedric
    Bes, Michele
    Vandenesch, Francois
    Tazir, Mohamed
    Hooijkaas, Herbert
    Verbrugh, Henri A.
    van Belkum, Alex
    Etienne, Jerome
    Lina, Gerard
    Ramdani-Bouguessa, Nadjia
    van Wamel, Willem J. B.
    CLINICAL INFECTIOUS DISEASES, 2010, 50 (01) : 61 - 68